Zelira Therapeutics

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Zelira Therapeutics was formerly known as Zelda Therapeutics, a Perth-based biotechnology company formed to bring together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments.

The company listed on the ASX in October 2016, through the reverse takeover of Gleneagle Gold.

In December 2019, Zelda Therapeutics acquired Ilera Therapeutics and changed its name to Zelira Therapeutics.

Contact Details

Level 3, 101 St Georges Terrace , PERTH WA 6000
08 6558 0886
zeliratx.com

Lists and Charts

Share price

Zelira Therapeutics
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
1221st /Company/Spenda -28.57% 4.56%
1222nd /Company/Z-Energy -28.57% -42.42%
1223rd /Company/Zelira-Therapeutics -28.57% -42.42%
1224th /Company/AVA-Risk-Group -28.58% 7.42%
1225th /Company/Elanor-Investors-Group -28.67% -12.83%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Revenue

Rank Company #
161st Down InteliCare $1.21m
162nd Down TV2U International $1.14m
163rd Down I Synergy Group $1.14m
164th Down Zelira Therapeutics $1.02m
198 public companies - industrial WA ranked by total revenue
View Full List

Company Share Transactions

24/11/23
$94.67k Issued
Zelira Therapeutics
24/11/23
$71.00k Issued
Zelira Therapeutics
24/11/23
$82.84k Issued
Zelira Therapeutics
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: Greg Blake, Executive Director 14 Aug 2024
NEW ROLE: Donna O?Donnell, 08 Jan 2024
NEWS: Tagged in Board Moves May 31 to June 2, 2023 07 Jun 2023
Donna Gentile O'Donnell
NEW ROLE: Donna Gentile O'Donnell, Non-Executive Director 07 Jun 2023
NEWS: Tagged in Board Moves February 20, 2023 20 Feb 2023
Greg Blake
NEW ROLE: Greg Blake, Vice President & Global Head of Commercial & Partnering, Executive Director since 2023 20 Feb 2023
NEWS: Tagged in Board Moves May 12, 2022 12 May 2022

News Articles

Related Information

Access to our data for Zelira Therapeutics is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Zelira Therapeutics is included in 1 list - Public Companies - Industrial WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X